HAVCR2 and autoimmune disease: Tim-3 was initially identified expressed on activated Th1 cells, rather than Th2 cells, and the interaction between Tim-3 and its ligand, galectin-9 (gal-9), was shown to inhibit Th1 responses and induce cell death in individuals with autoimmune disorders [3]–[6].